Dr. Seble Kassaye, MD

Dr. Kassaye practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Dr. Kassaye's NPI, 1720154545, was assigned on November 24, 2006. Dr. Kassaye graduated from Pritzker School of Medicine in 1998. Dr. Kassaye holds District of Columbia license MD038263.

Dr. Kassaye's primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-1400.

Dr. Kassaye's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dr. Kassaye is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Kassaye to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kassaye practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Kassaye's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Kassaye is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Kassaye's licenses on file in 3 states: District of Columbia, Virginia and California.

Dmand AI lists hiv/aids among the conditions Dr. Kassaye treats.

CMS data shows 102 Medicare services from Dr. Kassaye across 2 procedure codes in 2024, for 66 Medicare patients. Medicare paid $10,552 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Kassaye in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 35% are also on Medicaid. Their average risk score is 5.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kassaye's median patient age at 59, with 60% women.

In 2024, Dr. Kassaye wrote 107 Medicare Part D claims for 12 patients. 10% of them were for generic drugs. CMS names the drug for 81 of them, across 4 drugs with 11 or more claims each, at $242,663 in total drug cost. In 2023, CMS named 140 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Kassaye for performance year 2024, reported as part of a group. Dr. Kassaye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 176 papers to Dr. Kassaye, published from 2006 to 2025. 2021 was the busiest year, with 23. The most frequent topics are HIV Infections, HIV-1 and Anti-HIV Agents. Dr. Kassaye has published most often in AIDS. Dr. Kassaye's most frequent co-authors are Mardge Hillary Cohen, MD, Phyllis Tien and Margaret A. Fischl, MD.

Dmand AI links Dr. Kassaye to 1 clinical trial. Conditions studied include Convalescence and COVID-19.

CMS Open Payments shows 3 general payments to Dr. Kassaye from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $117.

Dr. Kassaye graduated from Pritzker School of Medicine in 1998.

Dr. Kassaye is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.